Michael Boice
International Drug Development(FR)
Publications by Year
Research Areas
MicroRNA in disease regulation, RNA Interference and Gene Delivery, Redox biology and oxidative stress, Cancer-related molecular mechanisms research, Glutathione Transferases and Polymorphisms
Most-Cited Works
- → Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells(2016)242 cited
- → MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia(2014)110 cited
- → MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia(2014)69 cited
- → A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers(2012)50 cited
- → Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia(2014)41 cited
- → Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy(2014)33 cited
- → 108 POSTER Screening Plasma Thioredoxin-1 (Trx-1) to potentially guide clinical development of the Trx-1 Inhibitor PX-12(2008)2 cited
- → Abstract LB343: Antitumor and metabolomic evaluation of immune checkpoint inhibition in diet-induced obese mice(2023)
- MiR-128 is a novel PHF6 targeting regulatory non-coding RNA acting as a T-ALL oncogene(2013)
- Pharmacodynamic evaluation of plasma thioredoxin-1 for patient enrichment of PX-12 clinical trials.(2008)